• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bidirectional relationship between cardiac extracellular matrix and cardiac cells in ischemic heart disease.缺血性心脏病中心脏细胞外基质与心脏细胞的双向关系。
Stem Cells. 2021 Dec;39(12):1650-1659. doi: 10.1002/stem.3445. Epub 2021 Sep 4.
2
Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction.基于生物杂交心脏细胞外基质的水凝胶可改善心肌梗死后的长期心脏功能。
Acta Biomater. 2017 Mar 1;50:220-233. doi: 10.1016/j.actbio.2016.12.015. Epub 2016 Dec 9.
3
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease.细胞外基质治疗缺血性心脏病的现状。
Med Sci (Basel). 2024 Jan 29;12(1):8. doi: 10.3390/medsci12010008.
4
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.缺血性和非缺血性心力衰竭中的细胞外基质。
Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20.
5
Combinatorial extracellular matrix microenvironments promote survival and phenotype of human induced pluripotent stem cell-derived endothelial cells in hypoxia.组合性细胞外基质微环境促进人诱导多能干细胞衍生的内皮细胞在缺氧条件下的存活和表型。
Acta Biomater. 2016 Oct 15;44:188-99. doi: 10.1016/j.actbio.2016.08.003. Epub 2016 Aug 4.
6
Extracellular matrix-based biomaterials for cardiac regeneration and repair.基于细胞外基质的生物材料用于心脏再生和修复。
Heart Fail Rev. 2021 Sep;26(5):1231-1248. doi: 10.1007/s10741-020-09953-9.
7
Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.去细胞化的新生心脏细胞外基质可预防成年哺乳动物心肌梗死后的广泛心室重构。
Acta Biomater. 2019 Mar 15;87:140-151. doi: 10.1016/j.actbio.2019.01.062. Epub 2019 Jan 30.
8
Role of Extracellular Matrix in Cardiac Cellular Therapies.细胞外基质在心脏细胞治疗中的作用。
Adv Exp Med Biol. 2018;1098:173-188. doi: 10.1007/978-3-319-97421-7_9.
9
The interplay between extracellular matrix and progenitor/stem cells during wound healing: Opportunities and future directions.细胞外基质与祖细胞/干细胞在创伤愈合中的相互作用:机遇与未来方向。
Acta Histochem. 2021 Oct;123(7):151785. doi: 10.1016/j.acthis.2021.151785. Epub 2021 Sep 6.
10
Novel xeno-free human heart matrix-derived three-dimensional scaffolds.新型无动物源的人心脏基质衍生三维支架
J Transl Med. 2015 Jun 18;13:194. doi: 10.1186/s12967-015-0559-0.

引用本文的文献

1
Three-Dimensional iPSC-Based In Vitro Cardiac Models for Biomedical and Pharmaceutical Research Applications.基于三维 iPSC 的体外心脏模型在生物医学和药物研发中的应用。
Int J Mol Sci. 2024 Oct 4;25(19):10690. doi: 10.3390/ijms251910690.
2
Delivery of Stem Cells and BMP-2 With Functionalized Self-Assembling Peptide Enhances Regeneration of Infarcted Myocardium.利用功能化自组装肽递送干细胞和骨形态发生蛋白-2可增强梗死心肌的再生
Stem Cell Rev Rep. 2024 Aug;20(6):1540-1554. doi: 10.1007/s12015-024-10721-7. Epub 2024 Apr 24.
3
Laminin Alpha 2 Enhances the Protective Effect of Exosomes on Human iPSC-Derived Cardiomyocytes in an In Vitro Ischemia-Reoxygenation Model.层粘连蛋白α 2 增强外泌体在体外缺血再灌注模型中对人诱导多能干细胞源性心肌细胞的保护作用。
Int J Mol Sci. 2024 Mar 28;25(7):3773. doi: 10.3390/ijms25073773.
4
APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.APJ作为肽类似物在心肌梗死和高血压诱导的心力衰竭中的有前景的治疗靶点。
Pharmaceutics. 2023 May 4;15(5):1408. doi: 10.3390/pharmaceutics15051408.
5
Knockdown of deleterious miRNA in progenitor cell-derived small extracellular vesicles enhances tissue repair in myocardial infarction.敲除祖细胞来源的小细胞外囊泡中的有害 miRNA 可增强心肌梗死后的组织修复。
Sci Adv. 2023 Mar 3;9(9):eabo4616. doi: 10.1126/sciadv.abo4616.

本文引用的文献

1
AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis.腺相关病毒介导的心脏成纤维细胞中 YAP 的表达促进炎症反应并增加纤维化。
Sci Rep. 2021 May 18;11(1):10553. doi: 10.1038/s41598-021-89989-5.
2
Extracellular matrix influences astrocytic extracellular vesicle function in wound repair.细胞外基质影响创伤修复中天 胶质细胞细胞外囊泡的功能。
Brain Res. 2021 Jul 15;1763:147462. doi: 10.1016/j.brainres.2021.147462. Epub 2021 Apr 1.
3
Engineering Human Cardiac Muscle Patch Constructs for Prevention of Post-infarction LV Remodeling.构建工程化人心脏肌肉补片以预防心肌梗死后左心室重构。
Front Cardiovasc Med. 2021 Feb 26;8:621781. doi: 10.3389/fcvm.2021.621781. eCollection 2021.
4
Extracellular-Matrix-Reinforced Bioinks for 3D Bioprinting Human Tissue.用于三维生物打印人体组织的细胞外基质增强生物墨水。
Adv Mater. 2021 Jan;33(3):e2005476. doi: 10.1002/adma.202005476. Epub 2020 Dec 9.
5
Effect of cellular and ECM aging on human iPSC-derived cardiomyocyte performance, maturity and senescence.细胞和细胞外基质衰老对人诱导多能干细胞源性心肌细胞功能、成熟和衰老的影响。
Biomaterials. 2021 Jan;268:120554. doi: 10.1016/j.biomaterials.2020.120554. Epub 2020 Nov 22.
6
Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling.miR-30d 通过细胞内和旁分泌信号调节心脏重塑。
Circ Res. 2021 Jan 8;128(1):e1-e23. doi: 10.1161/CIRCRESAHA.120.317244. Epub 2020 Oct 22.
7
Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition.成纤维细胞YAP的阻断通过抑制MRTF-A减轻心脏纤维化和功能障碍。
JACC Basic Transl Sci. 2020 Sep 28;5(9):931-945. doi: 10.1016/j.jacbts.2020.07.009. eCollection 2020 Sep.
8
Matrix-Bound Nanovesicles: The Effects of Isolation Method upon Yield, Purity, and Function.基质结合纳米囊泡:分离方法对产量、纯度和功能的影响
Tissue Eng Part C Methods. 2020 Oct;26(10):528-540. doi: 10.1089/ten.TEC.2020.0243.
9
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study.缺血性心脏病的全球流行病学:全球疾病负担研究结果
Cureus. 2020 Jul 23;12(7):e9349. doi: 10.7759/cureus.9349.
10
Extracellular vesicles influence the pulmonary arterial extracellular matrix in congenital diaphragmatic hernia.细胞外囊泡影响先天性膈疝中的肺动脉细胞外基质。
Pediatr Pulmonol. 2020 Sep;55(9):2402-2411. doi: 10.1002/ppul.24914. Epub 2020 Jul 8.

缺血性心脏病中心脏细胞外基质与心脏细胞的双向关系。

Bidirectional relationship between cardiac extracellular matrix and cardiac cells in ischemic heart disease.

机构信息

Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, Georgia, USA.

Children's Heart Research and Outcomes (HeRO) Center, Children's Healthcare of Atlanta & Emory University, Atlanta, Georgia, USA.

出版信息

Stem Cells. 2021 Dec;39(12):1650-1659. doi: 10.1002/stem.3445. Epub 2021 Sep 4.

DOI:10.1002/stem.3445
PMID:34480804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8725061/
Abstract

Ischemic heart diseases (IHDs), including myocardial infarction and cardiomyopathies, are a leading cause of mortality and morbidity worldwide. Cardiac-derived stem and progenitor cells have shown promise as a therapeutic for IHD but are limited by poor cell survival, limited retention, and rapid washout. One mechanism to address this is to encapsulate the cells in a matrix or three-dimensional construct, so as to provide structural support and better mimic the cells' physiological microenvironment during administration. More specifically, the extracellular matrix (ECM), the native cellular support network, has been a strong candidate for this purpose. Moreover, there is a strong consensus that the ECM and its residing cells, including cardiac stem cells, have a constant interplay in response to tissue development, aging, disease progression, and repair. When externally stimulated, the cells and ECM work together to mutually maintain the local homeostasis by initially altering the ECM composition and stiffness, which in turn alters the cellular response and behavior. Given this constant interplay, understanding the mechanism of bidirectional cell-ECM interaction is essential to develop better cell implantation matrices to enhance cell engraftment and cardiac tissue repair. This review summarizes current understanding in the field, elucidating the signaling mechanisms between cardiac ECM and residing cells in response to IHD onset. Furthermore, this review highlights recent advances in native ECM-mimicking cardiac matrices as a platform for modulating cardiac cell behavior and inducing cardiac repair.

摘要

缺血性心脏病(IHD),包括心肌梗死和心肌病,是全球范围内导致死亡和发病的主要原因。心脏来源的干细胞和祖细胞已被证明是治疗 IHD 的一种有前途的方法,但由于细胞存活率低、保留率有限和快速冲洗,其应用受到限制。一种解决方法是将细胞包裹在基质或三维结构中,以提供结构支撑并更好地模拟细胞在给药时的生理微环境。更具体地说,细胞外基质(ECM),即天然的细胞支持网络,是该目的的强有力候选者。此外,人们强烈认为 ECM 及其驻留细胞(包括心脏干细胞)在组织发育、衰老、疾病进展和修复过程中始终存在相互作用。当受到外部刺激时,细胞和 ECM 共同作用,通过最初改变 ECM 组成和刚度来相互维持局部内稳态,进而改变细胞的反应和行为。鉴于这种持续的相互作用,了解细胞-ECM 相互作用的双向机制对于开发更好的细胞植入基质以增强细胞植入和心脏组织修复至关重要。本综述总结了该领域的现有认识,阐明了心脏 ECM 与驻留细胞在 IHD 发生时的信号转导机制。此外,本综述还强调了模拟天然 ECM 的心脏基质作为调节心脏细胞行为和诱导心脏修复的平台的最新进展。